Divi's Laboratories Limited Stock price

Equities

DIVISLAB

INE361B01024

Pharmaceuticals

Market Closed - NSE India S.E. 08:01:59 2024-03-28 am EDT 5-day change 1st Jan Change
3,445 INR +2.30% Intraday chart for Divi's Laboratories Limited +0.50% -11.75%
Sales 2024 * 76.97B 923M Sales 2025 * 89.06B 1.07B Capitalization 894B 10.72B
Net income 2024 * 15.62B 187M Net income 2025 * 20.47B 246M EV / Sales 2024 * 11 x
Net cash position 2024 * 45.65B 548M Net cash position 2025 * 47.84B 574M EV / Sales 2025 * 9.5 x
P/E ratio 2024 *
56.6 x
P/E ratio 2025 *
43.3 x
Employees 8,433
Yield 2024 *
0.75%
Yield 2025 *
0.86%
Free-Float 47.69%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Divi's Laboratories Limited

1 day+2.68%
1 week-0.21%
Current month-0.88%
1 month-1.72%
3 months-12.23%
6 months-5.65%
Current year-11.42%
More quotes
1 week
3 350.00
Extreme 3350
3 476.35
1 month
3 350.00
Extreme 3350
3 652.05
Current year
3 350.00
Extreme 3350
4 074.40
1 year
2 792.70
Extreme 2792.7
4 074.40
3 years
2 730.00
Extreme 2730
5 425.10
5 years
1 466.00
Extreme 1466
5 425.10
10 years
532.65
Extreme 532.65
5 425.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 01-08-09
Founder 73 90-10-11
Director of Finance/CFO 74 94-11-19
Members of the board TitleAgeSince
Founder 73 90-10-11
Chief Executive Officer 46 01-08-09
Director/Board Member 66 94-12-25
More insiders
Date Price Change Volume
24-03-28 3,445 +2.30% 1 145 370
24-03-27 3,368 -0.68% 506,472
24-03-26 3,391 -1.18% 478,462
24-03-22 3,431 -0.98% 409,887
24-03-21 3,465 +1.08% 279,116

Delayed Quote NSE India S.E., March 28, 2024 at 04:00 am EDT

More quotes
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
24
Last Close Price
3,368 INR
Average target price
3,400 INR
Spread / Average Target
+0.95%
Consensus
  1. Stock
  2. Equities
  3. Stock Divi's Laboratories Limited - NSE India S.E.